Evaluation of the role of [18F]FDG-PET/CT and [ 68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids

Cancer Imaging

Volumn 11, Issue 1, 2011, Pages 70-75

  Jindal, Tarun ^a   Kumar, Arvind ^a   Venkitaraman, Balasubramanian ^a   Meena, Monika ^a   Kumar, Rakesh ^a   Malhotra, Arun ^a   Dutta, Roman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

1,4,7,10 tetraazacyclododecane N I IIII tetraacetic acid (D) Phe1 Thy3 octreotide positron emission tomography computed tomography; 68Ga DOTATOC PET CT; 18F fluorodeoxyglucose positron emission tomography computed tomography; 18F FDG PET CT; Atypical carcinoids; Typical carcinoids

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE N',N'',N''',N'''' TETRAACETIC ACID OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE] GA 68; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; OCTREOTIDE[3 TYROSINE]; UNCLASSIFIED DRUG; (DOTA(0) PHE(1) TYR(3))OCTREOTIDE; (DOTA(0)-PHE(1)-TYR(3))OCTREOTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GALLIUM; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; ATYPICAL CARCINOID; CANCER CLASSIFICATION; CANCER SURGERY; CARCINOID; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; LUNG SURGERY; LUNG TUMOR; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME; TYPICAL CARCINOID; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY;

ADOLESCENT; ADULT; CARCINOID TUMOR; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960493573     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2011.0010     Document Type: Article

References (13)

1. Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119: 1647-51. doi:10.1378/chest.119.6.1647. (Pubitemid 32744917)
2. Filosso PL, Rena O, Donati G, et al. Bronchial carcinoid tumours: surgical management and long-term outcome. J Thorac Cardiovasc Surg 2002; 123: 303-9. doi:10.1067/mtc.2002.119886. (Pubitemid 34127118)
3. Martini N, Zaman MB, Bains MS, et al. Treatment and prognosis in bronchial carcinoid involving regional lymph nodes. J Thorac Cardiovasc Surg 1994; 107: 1-7. (Pubitemid 24050491)
4. Chong S, Lee KS, Kim BT, et al. Integrated PET/CT of pulmonary neuroendocrine tumours: diagnostic and prognostic implications. AJR Am J Roentgenol 2007; 188: 1223-31. doi:10.2214/AJR.06.0503. (Pubitemid 46668502)
5. Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumours presenting as pulmonary nodules. Chest 2007; 131: 255-60. doi:10.1378/chest.06-0711. (Pubitemid 46123001)
6. Hofmann M, Maecke H, Borner R, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001; 28: 1751-57. (Pubitemid 33815052)
7. 3-octreotide PET in neuroendocrine tumours: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007; 48: 508-18. doi:10.2967/jnumed.106.035667.
8. Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993; 72: 82-90. doi:10.1002/1097-0142(19930701)72:1〈82::AID- CNCR2820720117〉3.0.CO;2-3. (Pubitemid 23182054)
9. Erasmus JJ, McAdams HP, Patz EF Jr. Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumours using FDG PET. AJR Am J Roentgenol 1998; 170: 1369-73. (Pubitemid 28210961)
10. Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumours on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol 2004; 182: 1129-32. (Pubitemid 38525502)
11. Wartski M, Alberini JL, Leroy-Ladurie F, et al. Typical and atypical bronchopulmonary carcinoid tumours on FDG PET/CT imaging. Clin Nucl Med 2004; 29: 752-53. doi:10.1097/00003072-200411000-00026. (Pubitemid 39410835)
12. 18F-FDG PET/CT in pulmonary neuroendocrine tumours. J Nucl Med 2009; 50: 1927-32. doi:10.2967/jnumed.109. 066639.
13. 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 2006; 33: 1115-22. doi:10.1007/s00259-006-0110-x.